このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Zhende Medical マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Jianguo Lu

最高経営責任者

CN¥1.6m

報酬総額

CEO給与比率	n/a
CEO在任期間	7.9yrs
CEOの所有権	1.5%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	1.9yrs

経営陣の近況

Recent updates

Does Zhende Medical (SHSE:603301) Have A Healthy Balance Sheet?

Apr 29

CEO（最高経営責任者

Jianguo Lu (54 yo)

7.9yrs

在職期間

CN¥1,600,000

報酬

Mr. Jianguo Lu is Chairman of the Board and General Manager of Zhende Medical Co., Ltd. from July 07, 2016.

取締役

名称	ポジション	在職期間	報酬	所有権
Jianguo Lu	Chairman of the Board & GM	7.9yrs	CN¥1.60m	1.47% CN¥ 79.5m
Zhendong Shen	Director & Deputy GM	no data	CN¥932.40k	0.22% CN¥ 12.1m
Dasheng Xu	Deputy GM & Director	no data	CN¥1.49m	0.098% CN¥ 5.3m
Jia Feng Wang	Independent Director	no data	CN¥121.60k	0.00019% CN¥ 10.3k
Sheng Xiao Li	Independent Director	1.9yrs	CN¥64.90k	データなし
Xiantao Zhang	Director	no data	CN¥635.00k	0.033% CN¥ 1.8m
Xiuyuan Hu	Chairman of the Supervisory Board	no data	データなし	0.044% CN¥ 2.3m
Chafen Zhu	Independent Director	1.9yrs	データなし	データなし

1.9yrs

平均在職期間

50yo

平均年齢

経験豊富なボード: 603301の取締役会は経験豊富ではない ( 1.9年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

Zhende Medical マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Zhende Medical Co., Ltd., Annual General Meeting, May 20, 2024

Zhende Medical Co., Ltd., Annual General Meeting, May 20, 2024

Less than half of directors are independent

No independent directors

Recent updates

Does Zhende Medical (SHSE:603301) Have A Healthy Balance Sheet?

Zhende Medical Co., Ltd., Annual General Meeting, May 20, 2024

Zhende Medical Co., Ltd., Annual General Meeting, May 20, 2024

New major risk - Financial data availability

Zhende Medical Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Investor sentiment deteriorates as stock falls 18%

Now 23% undervalued after recent price drop

New major risk - Revenue and earnings growth

Zhende Medical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024

New major risk - Financial data availability

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: CN¥0.34 (vs CN¥0.71 in 2Q 2022)

Zhende Medical Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023

First quarter 2023 earnings released: EPS: CN¥0.55 (vs CN¥0.50 in 1Q 2022)

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.81 (vs CN¥0.46 in 3Q 2021)

Investor sentiment improved over the past week

Zhende Medical Co., Ltd. announced that it has received CNY 976.452074 million in funding from Zhejiang Zhende Holding Co., Ltd., Xuchang Zhende Landscaping Engineering Co., Ltd.

Second quarter 2022 earnings released: EPS: CN¥0.71 (vs CN¥0.54 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

No independent directors

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.46 (vs CN¥5.57 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.54 (vs CN¥4.63 in 2Q 2020)

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS CN¥1.12 (vs CN¥0.44 in 1Q 2020)

New 90-day low: CN¥56.86

New 90-day low: CN¥59.35

Third quarter earnings released

Zhende Medical Co., Ltd. to Report Q3, 2020 Results on Oct 29, 2020

Earnings released

New 90-day high - CN¥99.22

Zhende Medical Co., Ltd. to Report First Half, 2020 Results on Aug 18, 2020

CEO（最高経営責任者

在職期間

報酬

取締役

平均在職期間

平均年齢

マネジメント基準チェック /14